1.70
price down icon0.58%   -0.01
after-market Handel nachbörslich: 1.70
loading
Schlusskurs vom Vortag:
$1.71
Offen:
$1.72
24-Stunden-Volumen:
373.77K
Relative Volume:
0.73
Marktkapitalisierung:
$244.72M
Einnahmen:
$34.16M
Nettoeinkommen (Verlust:
$-50.62M
KGV:
-3.3465
EPS:
-0.508
Netto-Cashflow:
$703.00K
1W Leistung:
-6.59%
1M Leistung:
+5.59%
6M Leistung:
-3.95%
1J Leistung:
-58.13%
1-Tages-Spanne:
Value
$1.68
$1.795
1-Wochen-Bereich:
Value
$1.59
$1.855
52-Wochen-Spanne:
Value
$1.22
$4.87

Omniab Inc Stock (OABI) Company Profile

Name
Firmenname
Omniab Inc
Name
Telefon
510-250-7800
Name
Adresse
5980 HORTON STREET, EMERYVILLE
Name
Mitarbeiter
114
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
OABI's Discussions on Twitter

Vergleichen Sie OABI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
OABI
Omniab Inc
1.70 231.77M 34.16M -50.62M 703.00K -0.508
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
408.61 105.69B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.07 61.52B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
569.17 60.69B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
837.28 50.05B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.02 35.25B 4.56B -176.77M 225.30M -1.7177

Omniab Inc Stock (OABI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-11-29 Eingeleitet RBC Capital Mkts Outperform
2023-04-21 Eingeleitet The Benchmark Company Buy
2023-04-13 Eingeleitet Craig Hallum Buy
2023-02-22 Eingeleitet Cowen Outperform
2023-02-13 Eingeleitet H.C. Wainwright Buy
2022-12-20 Eingeleitet Truist Buy
2022-12-16 Eingeleitet Credit Suisse Outperform
2022-11-29 Eingeleitet SVB Leerink Outperform
2022-11-28 Eingeleitet Stifel Buy
Alle ansehen

Omniab Inc Aktie (OABI) Neueste Nachrichten

pulisher
Oct 16, 2025

Risk vs reward if holding onto OmniAb Inc. Equity WarrantMarket Volume Summary & Low Risk Profit Maximizing Plans - newser.com

Oct 16, 2025
pulisher
Oct 16, 2025

Does OmniAb Inc. show high probability of reboundMarket Performance Recap & Stock Portfolio Risk Management - newser.com

Oct 16, 2025
pulisher
Oct 16, 2025

Using Bollinger Bands to evaluate OmniAb Inc.Quarterly Profit Review & Free Expert Approved Momentum Trade Ideas - newser.com

Oct 16, 2025
pulisher
Oct 16, 2025

OmniAb to Participate in Three Investor Conferences in November - Yahoo Finance

Oct 16, 2025
pulisher
Oct 15, 2025

Will OmniAb Inc. stock continue dividend increasesJuly 2025 Chart Watch & High Accuracy Investment Entry Signals - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Using data models to predict OmniAb Inc. Equity Warrant stock movementJuly 2025 Summary & Free Technical Confirmation Trade Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

What momentum shifts mean for OmniAb Inc. Equity Warrant2025 Price Action Summary & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Applying Elliott Wave Theory to OmniAb Inc. Equity WarrantQuarterly Trade Report & AI Forecasted Entry and Exit Points - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Signal strength of OmniAb Inc. stock in tech scanners2025 Valuation Update & Advanced Technical Analysis Signals - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Quantitative breakdown of OmniAb Inc. recent moveDip Buying & Fast Momentum Stock Entry Tips - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Will OmniAb Inc. Equity Warrant stock deliver consistent dividendsJuly 2025 Reactions & Free Daily Entry Point Trade Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Automated trading signals detected on OmniAb Inc.Weekly Trend Recap & Free Technical Pattern Based Buy Signals - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Published on: 2025-10-15 04:35:34 - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Evaluating OmniAb Inc. Equity Warrant with trendline analysisJuly 2025 Movers & Safe Capital Growth Trade Ideas - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

OmniAb (NASDAQ:OABI) Receives Sell (E+) Rating from Weiss Ratings - Defense World

Oct 15, 2025
pulisher
Oct 14, 2025

OmniAb to Report Third Quarter 2025 Financial Results on November 4 - PharmiWeb.com

Oct 14, 2025
pulisher
Oct 14, 2025

Press Release: OmniAb to Report Third Quarter 2025 Financial Results on November 4 - 富途牛牛

Oct 14, 2025
pulisher
Oct 14, 2025

How OmniAb Inc. stock compares to industry benchmarksQuarterly Market Summary & Reliable Price Action Trade Plans - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Technical analysis overview for OmniAb Inc. stock2025 Trading Recap & Technical Entry and Exit Alerts - newser.com

Oct 14, 2025
pulisher
Oct 12, 2025

Will OmniAb Inc. stock go up soonSell Signal & AI Powered Market Entry Strategies - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Can swing trading help recover from OmniAb Inc. lossesJuly 2025 Update & Daily Chart Pattern Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Live market analysis of OmniAb Inc.Volume Spike & Precise Buy Zone Identification - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

OmniAb, Inc. (NASDAQ:OABI) Not Lagging Industry On Growth Or Pricing - simplywall.st

Oct 10, 2025
pulisher
Oct 10, 2025

What institutional flow reveals about OmniAb Inc.Earnings Growth Report & Low Risk Entry Point Guides - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Can Filatex India Limited Stock Sustain Its Uptrend in a Bear MarketBreakout Stock Watch & Low Cost Investment Portfolio - earlytimes.in

Oct 09, 2025
pulisher
Oct 09, 2025

OmniAb Inc. Equity Warrant stock trend outlook and recovery pathJuly 2025 Momentum & Reliable Intraday Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Understanding OmniAb Inc.’s price movementTrade Risk Report & Risk Controlled Daily Plans - newser.com

Oct 09, 2025

Finanzdaten der Omniab Inc-Aktie (OABI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Omniab Inc-Aktie (OABI) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Love Steven
Director
May 14 '25
Buy
1.46
25,000
36,500
38,333
HIGGINS JOHN L
Director
May 12 '25
Buy
1.44
65,000
93,600
2,831,887
FOEHR MATTHEW W
President and CEO
Apr 07 '25
Option Exercise
0.00
36,458
0
3,815,618
FOEHR MATTHEW W
President and CEO
Apr 07 '25
Sale
2.00
19,382
38,764
3,796,236
Berkman Charles S
Chief Legal Officer
Apr 07 '25
Option Exercise
0.00
13,542
0
370,418
Berkman Charles S
Chief Legal Officer
Apr 07 '25
Sale
2.00
7,206
14,412
363,212
GUSTAFSON KURT A
Executive VP, Finance and CFO
Apr 07 '25
Option Exercise
0.00
13,542
0
231,034
GUSTAFSON KURT A
Executive VP, Finance and CFO
Apr 07 '25
Sale
2.00
7,206
14,412
223,828
$21.97
price down icon 2.96%
$87.31
price down icon 0.95%
$32.75
price up icon 0.09%
$105.08
price up icon 0.71%
$163.19
price down icon 0.21%
biotechnology ONC
$318.02
price up icon 0.59%
Kapitalisierung:     |  Volumen (24h):